Expression of tumor suppressive microRNA-34a is associated with a reduced risk of bladder cancer recurrence

Andrew, Angeline S.; Marsit, Carmen J.; Schned, Alan R.; Seigne, John D.; Kelsey, Karl T.; Moore, Jason H.; Perreard, Laurent; Karagas, Margaret R.; Sempere, Lorenzo F.

doi:10.1002/ijc.29413

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Expression of tumor suppressive microRNA-34a is associated with a reduced risk of bladder cancer recurrence

Published Date:

Feb 25 2015

Publisher's site:

http://dx.doi.org/10.1002/ijc.29413 New Site Icon

Source:

Int J Cancer. 137(5):1158-1166.

[PDF-672.74 KB]

Details:

Personal Authors:

Andrew, Angeline S. ; Marsit, Carmen J. ; Schned, Alan R. ; Seigne, John D. ; Kelsey, Karl T. ; ... More ▼

Keywords:

[+]

Pubmed ID:

25556547

Pubmed Central ID:

PMC4485975

Description:

Bladder cancer is the fourth most common cancer among men in the United States and more than half of patients experience recurrences within 5 years after initial diagnosis. Additional clinically informative and actionable biomarkers of the recurrent bladder cancer phenotypes are needed to improve screening and molecular therapeutic approaches for recurrence prevention. MicroRNA-34a (miR-34a) is a short noncoding regulatory RNA with tumor suppressive attributes. We leveraged our unique, large, population-based prognostic study of bladder cancer in New Hampshire, United States to evaluate miR-34a expression levels in individual tumor cells to assess prognostic value. We collected detailed exposure and medical history data, as well as tumor tissue specimens from bladder patients and followed them long-term for recurrence, progression and survival. Fluorescence-based in situ hybridization assays were performed on urothelial carcinoma tissue specimens (n = 229). A larger proportion of the nonmuscle invasive tumors had high levels of miR-34a within the carcinoma cells compared to those tumors that were muscle invasive. Patients with high miR-34a levels in their baseline nonmuscle invasive tumors experienced lower risks of recurrence (adjusted hazard ratio 0.57, 95% confidence interval 0.34-0.93). Consistent with these observations, we demonstrated a functional tumor suppressive role for miR-34a in cultured urothelial cells, including reduced matrigel invasion and growth in soft agar. Our results highlight the need for further clinical studies of miR-34a as a guide for recurrence screening and as a possible candidate therapeutic target in the bladder.

Document Type:

Journal Article

Collection(s):

CDC Public Access

Funding:

Main Document Checksum:

[+]

Supporting Files:

	nihms651856f2b.gif	image/gif
	nihms651856f2b.jpg	image/jpeg
	nihms651856f2c.gif	image/gif
	nihms651856f2c.jpg	image/jpeg
	nihms651856f3.gif	image/gif
	nihms651856f3.jpg	image/jpeg
	nihms651856f4a.gif	image/gif
	nihms651856f4a.jpg	image/jpeg
	nihms651856f4b.gif	image/gif
	nihms651856f4b.jpg	image/jpeg
	NIHMS651856-supplement-Supp_FigureS1.tif	image/tiff
	nihms651856f5.gif	image/gif
	nihms651856f5.jpg	image/jpeg
	NIHMS651856-supplement-Supp_FigureS2.tif	image/tiff
	NIHMS651856-supplement-Supp_TableS1-S2.docx	application/vnd.openxmlformats-officedocument.wordprocessingml.document
	nihms651856.nxml	application/octet-stream
	nihms651856f1.gif	image/gif
	nihms651856f1.jpg	image/jpeg
	nihms651856f2a.gif	image/gif
	nihms651856f2a.jpg	image/jpeg

No Related Documents.

You May Also Like:

Microprocessor of microRNAs: regulation and potential for therapeutic intervention

Personal Author:

Beezhold, Kevin J; Castranova, Vince; Chen, Fei;

Published:

Jun 01 2010

Source:

Mol Cancer. 2010; 9:134.

Description:

MicroRNAs (miRNAs) are a class of small, noncoding RNAs critically involved in a wide spectrum of normal and pathological processes of cells or tissues by fine-tuning the signals important for stem cell development, cell differentiation, cell cycle r...

File Type:

[PDF - 1001.17 KB]
MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion

Personal Author:

Imani, Saber; Wei, Chunli; Cheng, Jingliang; Asaduzzaman Khan, Md.; Fu, Shangyi; Yang, Luquan; Tania, Mousumi; Zhang, Xianqin; Xiao, Xiuli; Zhang, Xianning; Fu, Junjiang;

Published:

Mar 28 2017

Source:

Oncotarget. 2017; 8(13):21362-21379.

Description:

MicroRNA-34a (miR-34a) plays an essential role against tumorigenesis and progression of cancer metastasis. Here, we analyzed the expression, targets and functional effects of miR-34a on epithelial to mesenchymal transition-inducing transcription fact...

File Type:

[PDF - 6.75 MB]
Genetic polymorphisms modify bladder cancer recurrence and survival in a U.S. population-based prognostic study

Personal Author:

Andrew, Angeline S.; Gui, Jiang; Hu, Ting; Wyszynski, Asaf; Marsit, Carmen J.; Kelsey, Karl T.; Schned, Alan R.; Tanyos, Sam A.; Pendleton, Eben M.; Ekstrom, Rebecca M.; Li, Zhongze; Zens, Michael S.; Borsuk, Mark; Moore, Jason H.; Karagas, Margaret R.;

Published:

Mar 26 2014

Source:

BJU Int. 115(2):238-247.

Description:

Objective : To identify genetic variants that modify bladder cancer prognosis focusing on genes involved in major biological carcinogenesis processes (apoptosis, proliferation, DNA repair, hormone regulation, immune surveillance, and cellular metabol...

File Type:

[PDF - 561.42 KB]
Unmasking molecular profiles of bladder cancer

Personal Author:

Piao, Xuan-Mei; Byun, Young Joon; Kim, Wun-Jae; Kim, Jayoung;

Published:

Feb 01 2018

Source:

Investig Clin Urol. 2018; 59(2):72-82.

Description:

Precision medicine is designed to tailor treatments for individual patients by factoring in each person's specific biology and mechanism of disease. This paradigm shifted from a "one size fits all" approach to "personalized and precision care" requir...

File Type:

[PDF - 365.55 KB]
Role of Epithelial-Mesenchyme Transition in Chlamydia Pathogenesis

Personal Author:

Igietseme, Joseph U.; Omosun, Yusuf; Stuchlik, Olga; Reed, Matthew S.; Partin, James; He, Qing; Joseph, Kahaliah; Ellerson, Debra; Bollweg, Brigid; George, Zenas; Eko, Francis O.; Bandea, Claudiu; Liu, Hsi; Yang, Genyan; Shieh, Wun-Ju; Pohl, Jan; Karem, Kevin; Black, Carolyn M.;

Published:

Dec 17 2015

Source:

PLoS One. 10(12).

Description:

Chlamydia trachomatis genital infection in women causes serious adverse reproductive complications, and is a strong co-factor for human papilloma virus (HPV)-associated cervical epithelial carcinoma. We tested the hypothesis that Chlamydia induces ep...

File Type:

[PDF - 14.05 MB]